Find policies, billing codes, payers, states, and providers
CPT 94664: Respiratory Device Education and Demonstration
Headline: CPT code 94664: Patient Education and Demonstration for Respiratory Device Use
Lead: CPT code 94664 captures a clinician-delivered education session in which a patient is instructed on and then demonstrates the correct use of an aerosol device, nebulizer, metered dose inhaler, or IPPB device as part of evaluation and management. The code is used across ambulatory and emergency settings and is relevant for management of asthma, COPD, and acute respiratory symptoms.
CPT code 94664 represents a targeted education and competency-demonstration service that supports effective self-management of inhaled therapies. Nationally, the code matters because proper device technique impacts medication delivery, clinical outcomes, and downstream utilization. Payers commonly consider documentation that education occurred and that the patient demonstrated understanding when adjudicating claims.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of the code, typical sites of service, common associated diagnoses, and how this service relates to other respiratory procedure codes. The publication also highlights coding context and related service lines to help health systems and clinicians align billing documentation with clinical workflows.
This summary is written for a national audience and focuses on the clinical and billing characteristics of CPT code 94664 without state-specific policy detail.
Customize your policy alerts
Sign up for cpt 94664 policy alerts
Get alerted when payer policies referencing 94664 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 94664 describes a clinical service in which a provider educates a patient on the use of an aerosol delivery device — such as a nebulizer, metered dose inhaler, or intermittent positive pressure breathing (IPPB) device — and then has the patient demonstrate their understanding. This education occurs as part of the evaluation and management of a patient who requires respiratory therapy.
-
Service type: Patient education and demonstration of device use, respiratory therapy
-
Typical site of service: Outpatient clinic or office setting, emergency department, or other ambulatory care environment where evaluation and management services are provided
National Reimbursement Benchmarks
Across national benchmarks for CPT 94664, Medicare’s mean of $20.9 sits well below BUCA’s average commercial mean of $53.5, indicating a sizable gap between public and this commercial grouping: BUCA averages roughly $32.6 higher than Medicare. That spread highlights payer-level differences in valuation for this respiratory procedure, with BUCA near the upper half of commercial means while Medicare remains clustered around $20–$22 across localities.
Dispersion measured by the interquartile range (P75 minus P25) varies meaningfully: Blue Cross Blue Shield shows the widest IQR at $25.7 (from $61.2 to $86.9), reflecting broader variability in negotiated rates, while Aetna and Cigna have moderate spreads of $20.1 and $18.7 respectively. UnitedHealth Group is among the tighter commercial distributions with an IQR of $16.4. BUCA’s IQR is $20.4 and Medicare’s IQR is $3, indicating Medicare rates are comparatively stable across localities.